DH Definitive Healthcare Corp.
Q3 2025 10-Q
Filed: Nov 6, 2025Period ending Sep 30, 2025
Information Technology
Services-Prepackaged SoftwareSEC EDGAR Definitive Healthcare Corp. (DH) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 6, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • New goodwill impairment risk triggered by Q1 2025 market cap decline, resulted in $176.5 million non-cash charge
- • Sales execution risk materially updated due to 2024 restructuring plan disrupting sales, impacting customer acquisition and renewal rates in 2025
Quarterly Financial SummaryXBRL
Revenue
$60M
▼ -4.2% YoY▼ -1.2% QoQ
Net Income
-$15M
▲ +88.7% YoY▼ -96.5% QoQ
Gross Margin
76.6%
▼ -161bp YoY▼ -13bp QoQ
Operating Margin
-14.5%
▲ +34499bp YoY▼ -760bp QoQ
Net Margin
-24.7%
▲ +18406bp YoY▼ -1228bp QoQ
ROE
-3.8%
Total Assets
$756M
EPS (Diluted)
$-0.15
▲ +86.6% YoY▼ -50.0% QoQ
Operating Cash Flow
$16M
▼ -19.3% YoY▲ +68.6% QoQ
Source: XBRL data from Definitive Healthcare Corp. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on Definitive Healthcare Corp.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.